Molecular mechanisms of innate immune host defense mediated by lung-surfactant proteins A and D

肺表面活性蛋白A和D介导的先天免疫宿主防御的分子机制

基本信息

  • 批准号:
    12470136
  • 负责人:
  • 金额:
    $ 9.22万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

Pulmonary surfactant proteins A and D (SP-A and SP-D) belong to the collectin subgroup of C-type lectin superfamily, along with mannose binding proteins. The collecting bind to bacterial components in addition to certain phospholipids and glyco-sphingolipids and interact with macrophages. The proteins have been known to play critical roles in innate immunity of the lung. CD14 and Toll-like receptors (TLR) function as pathogen receptors (pattern recognition receptors) and are essential for recognition and signal transduction of various pathogen. The purpose of this study was to investigate molecular mechanisms of innate immunity mediated by surfactant proteins and pattern recognition receptors.(1)Lung collecting SP-A arid SP-D, bind CD14 by different mechanisms. They alter LPS-CD14 interactions. MBP also binds CD14, suggesting that binding to CD14 is a unique property of collectin group.(2) Peptidoglycan (PGN) derived from Staphylococcus aureus is not a ligand for SP-A. SP-A significantly attenuates PGN-elicited TNF-alpha in U937 cells and rat alveolar macrophages. SP-A attenuates PGN-induced NF-kappa activation in HEK293 cells transfected with TLR2 CDNA. In addition, SP-A binds the soluble form of the extracellular TLR2 domain (sTLR2) which was produced in culovirus-irisect cell system, and alters the binding of sTLR2 to PGN. These results demonstrate that SP-A inhibits PGN-induced TNF-alpha secretion by direct interaction with TLR2.(3) The extracellular TLR2 domain has been onstrated to bind directlt to PGN, indicating the direct interaction of TLR2 with PGN activate NF-kappa B.(4) Analaysis with CD14/TLR2 chimera in which CD14 was substituted for the extracellular TLR2 domain has demonstrated that CD14 cannot functionally replace with the extracellular TLR2 domain. The studies with- several deletion mutants of TLR2 also demonastrate that the extracellular TLR2 region of ser40-Ile64 but not the region of Cys30-Ser39 is critical for PGN signaling mediated by TLR2.
肺表面活性物质蛋白A和D(SP-A和SP-D)与甘露糖结合蛋白一样,属于C型凝集素超家族中的胶凝素亚类。除了某些磷脂和糖鞘脂外,该集合体还与细菌成分结合,并与巨噬细胞相互作用。已知这些蛋白质在肺的先天免疫中发挥关键作用。CD14和Toll样受体(TLR)作为病原体受体(模式识别受体),在多种病原体的识别和信号转导中起着至关重要的作用。本研究旨在探讨肺表面活性蛋白和模式识别受体介导天然免疫的分子机制:(1)肺收集SP-A和SP-D,通过不同机制与CD14结合。它们改变了内毒素-CD14的相互作用。MBP还与CD14结合,提示与CD14的结合是集合素基团的独特性质。(2)金黄色葡萄球菌来源的肽聚糖(PGN)不是SP-A的配体。SP-A显著减弱PGN诱导的U937细胞和大鼠肺泡巨噬细胞的肿瘤坏死因子-α。SP-A抑制PGN诱导的TLR2 CDNA转染HEK293细胞中的NF-kappa活性。此外,SP-A还与库立克病毒免疫细胞系统中产生的胞外TLR2结构域的可溶性形式(STLR2)结合,并改变sTLR2与PGN的结合。这些结果表明,SP-A通过与TLR2的直接相互作用来抑制PGN诱导的肿瘤坏死因子-α的分泌。(3)细胞外TLR2结构域直接与PGN结合,提示TLR2与PGN直接相互作用激活了核因子-kappaB。(4)CD14/TLR2嵌合体分析表明,CD14取代了细胞外TLR2结构域,CD14不能取代细胞外TLR2结构域。对TLR2的几个缺失突变体的研究也表明,在TLR2介导的PGN信号转导中,Ser40-Ile64的胞外区域而不是Cys30-Ser39区域是关键的。

项目成果

期刊论文数量(138)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Bridges JP: "Pulmonary surfactant proteins A and D are potent ihibitors of lipids oxidationand oxidative celluelar injury"J Biol Chem. 275. 38848-38855 (2000)
Bridges JP:“肺表面活性蛋白 A 和 D 是脂质氧化和氧化细胞损伤的有效抑制剂”J Biol Chem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Cheng G: "Increased levels of surfactant protein A and D in bronchoalveolar lavage fluids in patients with bronchial asthma"Eur Respir J. 16. 831-835 (2000)
Cheng G:“支气管哮喘患者支气管肺泡灌洗液中表面活性蛋白 A 和 D 水平升高”Eur Respir J. 16. 831-835 (2000)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Chiba H.: "rat mannose-binding protein A binds CD14"Infact Immun.. 69. 1587-1592 (2001)
Chiba H.:“大鼠甘露糖结合蛋白 A 结合 CD14”Infact Immun.. 69. 1587-1592 (2001)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takahashi H: "Serum levels of surfactant proteins A and D are useful markers for interstitial lung disease in patients with progressive systemic sclerosis."Am J Respir Crit Care Med. 162. 258-263 (2000)
Takahashi H:“表面活性蛋白 A 和 D 的血清水平是进行性系统性硬化症患者间质性肺疾病的有用标志物。”Am J Respir Crit Care Med。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
高橋亨: "GM-CSFノックアウトマウス"分子呼吸器病. (印刷中). (2001)
Toru Takahashi:“GM-CSF 敲除小鼠”分子呼吸道疾病(印刷中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KUROKI Yoshio其他文献

KUROKI Yoshio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KUROKI Yoshio', 18)}}的其他基金

Mechanisms of host defense against pulmonaryinfection, inflammation and injury by surfactant proteins and studies on clinical applications
表面活性蛋白抵抗肺部感染、炎症和损伤的宿主防御机制及临床应用研究
  • 批准号:
    20390232
  • 财政年份:
    2008
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Host defense system in the lung using pulmonary surfactant proteins and Toll-like reosptors
使用肺表面活性蛋白和 Toll 样重反应器的肺部宿主防御系统
  • 批准号:
    18390241
  • 财政年份:
    2006
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mechanisms of innate immune surveillance by pulmonary surfactant proteins and their clinical application to respiratory infection.
肺表面活性蛋白的先天免疫监视机制及其在呼吸道感染中的临床应用。
  • 批准号:
    16390235
  • 财政年份:
    2004
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Clinical application for pathophysiological analysis, diagnosis and treatment of lung diseases by genes and their products expressed in alveolar type II cells.
肺泡II型细胞表达的基因及其产物在肺部疾病病理生理学分析、诊断和治疗中的临床应用。
  • 批准号:
    12557057
  • 财政年份:
    2000
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Host defense mechanism by pulmonary surfactant proteins A and D thiir clinical application
肺表面活性蛋白A和D的宿主防御机制及其临床应用
  • 批准号:
    10557058
  • 财政年份:
    1998
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Host defense mechanism and modulation of lipid metabolism by pulmonary surfactant proteins
宿主防御机制及肺表面活性蛋白对脂质代谢的调节
  • 批准号:
    09670159
  • 财政年份:
    1997
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanism of lung discases by analysis of surfactant protein A and its receptor.
通过表面活性蛋白A及其受体分析肺疾病的分子机制。
  • 批准号:
    07457147
  • 财政年份:
    1995
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Regulatory roles of pulmonary surfactant apoprotein and its receptor in metabolism of lung diseases.
肺表面活性物质脱辅基蛋白及其受体在肺部疾病代谢中的调节作用。
  • 批准号:
    03670406
  • 财政年份:
    1991
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

Collectin-12激活单核细胞及补体旁路途径参与肾小管损伤的机制研究
  • 批准号:
    82000730
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

CAREER: Decoding the Code of Glycan-Collectin Interactions: Computational Engineering of Surfactant Proteins for Tailored Glycan Recognition
职业:解码聚糖-收集素相互作用的密码:用于定制聚糖识别的表面活性剂蛋白的计算工程
  • 批准号:
    2338401
  • 财政年份:
    2024
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Continuing Grant
Roles of human surfactant collectin variants in the susceptibility of COVID-19
人类表面活性剂集合素变体在 COVID-19 易感性中的作用
  • 批准号:
    10510706
  • 财政年份:
    2022
  • 资助金额:
    $ 9.22万
  • 项目类别:
Roles of human surfactant collectin variants in the susceptibility of COVID-19
人类表面活性剂集合素变体在 COVID-19 易感性中的作用
  • 批准号:
    10662530
  • 财政年份:
    2022
  • 资助金额:
    $ 9.22万
  • 项目类别:
Prevention of Preterm Birth Using the Collectin Surfactant Protein A (SP-A)
使用集合素表面活性剂蛋白 A (SP-A) 预防早产
  • 批准号:
    10403521
  • 财政年份:
    2019
  • 资助金额:
    $ 9.22万
  • 项目类别:
Prevention of Preterm Birth Using the Collectin Surfactant Protein A (SP-A)
使用集合素表面活性剂蛋白 A (SP-A) 预防早产
  • 批准号:
    9913576
  • 财政年份:
    2019
  • 资助金额:
    $ 9.22万
  • 项目类别:
Characterisation of glycan ligands recognised by collectin-11 in ischaemic kidney and development of a specific antagonistic probe
缺血肾中collectin-11识别的聚糖配体的表征以及特异性拮抗探针的开发
  • 批准号:
    MR/R010757/1
  • 财政年份:
    2018
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Research Grant
Novel mechanism of complement activation by membrane-type collectin CL-P1
膜型集合素 CL-P1 激活补体的新机制
  • 批准号:
    17K08615
  • 财政年份:
    2017
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study on the involvement of collectin CL-K1 in the pathogenesis of 3MC syndrome and elucidation of its molecular mechanism
集合素CL-K1参与3MC综合征发病机制的研究及其分子机制的阐明
  • 批准号:
    16K19045
  • 财政年份:
    2016
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Collectin-11 as a trigger of the innate immune response in renal transplantation
Collectin-11 作为肾移植中先天免疫反应的触发因素
  • 批准号:
    MR/M012263/1
  • 财政年份:
    2015
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Research Grant
Pulmonary collectin regulates the severity of Streptococcus pneumoniae infection
肺集合素调节肺炎链球菌感染的严重程度
  • 批准号:
    15K09181
  • 财政年份:
    2015
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了